课题基金 / 基金详情

Outer Membrane Proteins of Francisella tularensis as Acellular Vaccines

Outer Membrane Proteins of Francisella tularensis as Acellular Vaccines
土拉弗朗西斯菌外膜蛋白作为无细胞疫苗
批准号:
7676562
负责人:
MICHAEL V. NORGARD
金额:
$47.28万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-15 至 2014-02-28

项目摘要

项目成果

MICHAEL V. NORGARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Outer membrane proteins (OMPs) and lipoproteins (IPs) of Gram-negative bacteria are of enormous importance as virulence factors, stabilizers of outer membrane integrity, and protective immune targets (vaccines). To date, little has been known regarding the OMPs of Francisella tularensis (Type A) strains that are pathogenic for humans (e.g., F. tularensis SCHU S4). However, selected OMPs could prove invaluable as subunit vaccines for tularemia. In this regard, we have achieved two important milestones that warrant further investigation of the OMPs as acellular vaccines for tularemia. First, we developed a sucrose density gradient method for the physical separation of the outer and cytoplasmic membranes of F. tularensis (J.F. Huntley et al., 2007, J. Bacteriol. 189:561). This method has allowed, for the first time, direct examination of the OMP components of this important Category A select agent. Second, we have demonstrated that OMP-immunized mice are protected against intranasal challenge with SCHU S4. We now wish to extend these studies by completing the identification of the entire spectrum of OMPs in F. tularensis SCHU S4 (Aim 1). We also will test native and recombinant OMPs of SCHU S4 for their vaccinogenic potentials using mouse models of tularemia (Aim 2). Various routes for mouse immunizations (intraperitoneal, intranasal) and pulmonary challenges (intranasal, aerosol) will be employed. As part of this initiative, we also will examine newer adjuvants (e.g., cationic lipid-DNA liposomes, ISCOMs, CpG, and AdDP) to potentially enhance immunoprotection. In Aim 3, we shall investigate the humoral aspect of protective immunity induced by OMP vaccines by performing passive transfer experiments in mice, and by assessing antibody classes and isotypes elicited. Included in these studies will be assessments of key correlates of protective immunity (Th1 and Th2 cytokines, regulators, etc.); humanized mice may be particularly useful for these studies. As an off-shoot of this project, we also shall evaluate the roles of selected OMPs and LPs as virulence factors for F. tularensis by examining OMP-deficient mutants in both in vitro (infection/growth in human monocytes) and in vivo (mouse infection) systems. The combined studies will provide important new knowledge for understanding F. tularensis pathogenesis and for devising new acellular vaccines for tularemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Outer Membrane Proteins of Francisella tularensis as Acellular Vaccines
Outer Membrane Proteins of Francisella tularensis as Acellular Vaccines
The RpoN-RpoS regulatory pathway in Borrelia burgdorferi
  • 批准号:
    7058223
  • 项目类别:
  • 资助金额:
    $38.08万
  • 财政年份:
    2004
  • 负责人:
    MICHAEL V. NORGARD
  • 依托单位:
The RpoN-RpoS regulatory pathway in Borrelia burgdorferi
  • 批准号:
    8610221
  • 项目类别:
  • 资助金额:
    $39.35万
  • 财政年份:
    2004
  • 负责人:
    MICHAEL V. NORGARD
  • 依托单位:
海外基金